发明名称 Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
摘要 The present disclosure provides functionalized magnetic nanoparticles (MNPs) comprising a functional group that binds to β-amyloid deposits and/or neurofibrillary tangles. The present disclosure provides compositions comprising the functionalized MNPs, and methods of using the functionalized MNPs in imaging β-amyloid deposits and neurofibrillary tangles.
申请公布号 US9272055(B2) 申请公布日期 2016.03.01
申请号 US201214007298 申请日期 2012.04.04
申请人 The Regents of the University of California 发明人 Akhtari Massoud
分类号 A61K31/44;A61K31/277;A61K49/10;A61K31/4745;A61K31/132;A61K31/133;A61K31/136;A61K31/145;A61K31/167;A61K31/427;A61K31/428;A61K31/4439;A61K31/444;A61K31/472;A61K49/18 主分类号 A61K31/44
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic, Field & Francis LLP ;Borden Paula A.
主权项 1. A pharmaceutical composition comprising: a) a functionalized magnetic nanoparticle (MNP) comprising a magnetic core and a functional group that binds aggregated β-amyloid protein and/or neurofibrillary tangles, wherein said functional group is coupled via an epoxy group to the magnetic core, wherein said functionalized magnetic nanoparticle is capable, when introduced into the bloodstream of a mammalian subject, of crossing the blood-brain barrier of a mammalian subject, and wherein the functional group is 2-(1-{6-[(2-hydroxyethyl)(methy)amino]-2-naphthyl}lethylidene)malononitrile(HODDNP), or a derivative or analog thereof; and b) a pharmaceutically acceptable carrier.
地址 Oakland CA US